Doppler ultrasound may be useful for patients with suspected GCA

Article

A study has found that doppler ultrasound may be useful in monitoring and diagnosis of patients with suspected giant cell arteritis (GCA).

A study has found that doppler ultrasound may be useful in monitoring and diagnosis of patients with suspected giant cell arteritis (GCA). The results are to be published in an issue of Clinical Ophthalmology.

Led by Dr Ana M. Suelves from La Fe University Hospital, Valencia, Spain, the researchers evaluated how useful ultrasound is in the diagnosis of GCA, in monitoring the response to corticotherapy and in detecting early relapses.

The study comprised 10 patients with suspected GCA who all underwent ultrasound examination of both temporal arteries before temporal artery biopsy (TAB), 3 weeks after starting treatment and 3 months after diagnosis. For the purposes of this study only histological findings were considered in defining whether the patients were suffering from GCA. All ultrasound results were compared with those from the biopsy and the best position to perform the biopsy was determined using ultrasound.

Using ultrasound, no false positive results were obtained and the results presented gave a sensibility, specificity and positive predictive value of 100% for the use of ultrasound in the diagnosis of GCA. Additionally, the researchers were able to detect two relapses early using ultrasound during the follow up period.

From the results it was concluded that the eco-doppler may be a useful tool in the diagnosis and clinical follow up of patients with suspected GCA.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.